文献速递产科

阴道播种对剖宫产婴儿肠道菌群、体重指数及过敏风险的影响:一项随机临床试验

Effects of vaginal seeding on gut microbiota, body mass index, and allergy risks in infants born through cesarean delivery: a randomized clinical trial.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-11-02

在湖南省浏阳市妇幼保健院开展的随机对照试验纳入120例计划剖宫产的单胎足月孕妇,按1:1随机分为阴道播种组和对照组,最终117例婴儿纳入分析。阴道播种对婴儿6、12、18、24月龄体重指数及18月龄过敏风险总分均无显著影响,未报告干预相关不良事件。

要点

  • 阴道播种组与对照组婴儿各时点体重指数及体重指数z评分均无显著差异。
  • 18月龄过敏风险总分中位数两组无显著差异,其他次要结局亦无差异。
  • 阴道播种组6月龄超重/肥胖风险较低,但后续时点无差异,未报告干预相关不良事件。

核心结论

  • 对于剖宫产婴儿,阴道播种在其出生后前2年内对肠道菌群、生长或过敏风险无显著影响。

研究设计与样本

  • 在湖南省浏阳市妇幼保健院开展的随机对照试验,2018年11月至2019年9月纳入120例计划剖宫产的单胎足月孕妇,按1:1随机分为阴道播种组(n=60)和对照组(n=60),婴儿随访于2021年9月完成,117例婴儿纳入分析。

主要发现

  • 6月龄时阴道播种组与对照组体重指数分别为17.5(1.4)kg/m2与17.8(1.8)kg/m2,均数差-0.31 kg/m2(95%CI,-0.91至0.28;P=.30),体重指数z评分分别为0.2(1.0)与0.4(1.1),均数差-0.20(95%CI,-0.58至0.18;P=.31),4个时点均无显著差异。
  • 18月龄过敏风险总分中位数阴道播种组为1.5(四分位距0.0-4.0),对照组为2.0(四分位距1.0-3.0),中位数差0.00(95%CI,-1.00至1.00;P=.48)。
  • 阴道播种组婴儿肠道菌群中乳杆菌属和拟杆菌属相对丰度在出生时和6月龄时略有升高但无显著差异。
  • 6月龄时阴道播种组超重/肥胖风险较低(0/57 vs 6/59;相对危险度0.03[95%CI,0.00-0.57];P=.03),但后续时点无差异,其他次要结局两组无差异。
  • 未报告与干预相关的不良事件。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaginal seeding-exposure of neonates to maternal vaginal fluids-has been proposed to improve the microbiota of infants born through cesarean delivery, but its impacts on the infants' subsequent health outcomes remain unclear. OBJECTIVE: This study aimed to examine the impacts of vaginal seeding on gut microbiota, growth, and allergy risks in infants born through cesarean delivery. STUDY DESIGN: This randomized controlled trial was conducted at Liuyang Maternal and Child Health Care Hospital in Hunan, China. We estimated that a minimum sample size of 106 was needed by assuming a standardized effect size of 0.6 for the primary outcomes, with a statistical power of 80%, a 2-sided type I error of 0.05, and an expected loss to follow-up rate of 15%. Finally, 120 singleton term pregnant women scheduled for cesarean delivery were enrolled from November 2018 to September 2019. Infant follow-up was completed in September 2021. The participants were randomized in a 1:1 ratio to the vaginal seeding group (n=60; infants were swabbed immediately after birth using gauze preincubated in maternal vagina) or the control group (n=60; routine standard care). The first set of primary outcomes was infant body mass index and body mass index z-scores at 6, 12, 18, and 24 months of age. The other primary outcome was the total allergy risk score at 18 months for 20 common allergens (each scored from 0-6 points). Characteristics of gut microbiota, overweight/obesity, and allergic diseases and symptoms were included as secondary outcomes. The main analyses were performed according to the modified intention-to-treat principle. RESULTS: Of 120 infants, 117 were included in the analyses. Infant body mass index and body mass index z-scores did not significantly differ between the 2 groups at any of the 4 time points, with the largest difference in point estimates occurring at 6 months: the mean (standard deviation) body mass index was 17.5 (1.4) kg/m2 and 17.8 (1.8) kg/m2 in the vaginal seeding and control groups, respectively (mean difference, -0.31 kg/m2 [95% confidence interval, -0.91 to 0.28]; P=.30), and body mass index z-score was 0.2 (1.0) and 0.4 (1.1), respectively (mean difference, -0.20 [95% confidence interval, -0.58 to 0.18]; P=.31). The median total allergy risk score was 1.5 (interquartile range, 0.0-4.0) in the vaginal seeding group and 2.0 (interquartile range, 1.0-3.0) in the control group (median difference, 0.00 [95% confidence interval, -1.00 to 1.00]; P=.48). For infants from the vaginal seeding group, the relative abundance of genera Lactobacillus and Bacteroides in the gut microbiota was slightly yet nonsignificantly elevated at birth and 6 months, and the risk of overweight/obesity was lower at 6 months (0/57 vs 6/59; relative risk, 0.03 [95% confidence interval, 0.00-0.57]; P=.03) though not at subsequent time points. Other secondary outcomes did not differ between groups. No adverse events related to the intervention were reported. CONCLUSION: For infants born through cesarean delivery, vaginal seeding has no significant impacts on the gut microbiota, growth, or allergy risks during the first 2 years of life.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Liu Y, Li HT, Zhou SJ, et al. Effects of vaginal seeding on gut microbiota, body mass index, and allergy risks in infants born through cesarean delivery: a randomized clinical trial. Am J Obstet Gynecol MFM. 2022. PMID: 36334724. doi:10.1016/j.ajogmf.2022.100793

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。